Concepedia

Kevin W. Bock

KW

Statistics

Publications

54

Citations

6.5K

H-Index

34

Active since

2004

Affiliations

National Institute of Allergy and Infectious Diseases(Current)

National Institutes of Health

Bioqual

Moderna Therapeutics (United States)

University of Maryland, College Park

Kevin W. Bock is an author at National Institute of Allergy and Infectious Diseases specializing in infectious diseases, immunology, and veterinary medicine.

ORCID

Publications per year

2004–2023

54

Publications

54

SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness

Kizzmekia S. Corbett, Darin K. Edwards, Sarah R. Leist et al. · Nature · 2020 · 1.7K citations · Full text

, , +14

Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates

Kizzmekia S. Corbett, Barbara J. Flynn, Kathryn E. Foulds et al. · New England Journal of Medicine · 2020 · 1.2K citations · Full text

, , +17

In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies

Dapeng Li, Robert J. Edwards, Kartik Manne et al. · Cell · 2021 · 332 citations · Full text

, , +16

Immune correlates of protection by mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates

Kizzmekia S. Corbett, Martha Nason, Britta Flach et al. · Science · 2021 · 329 citations · Full text

, , +17

Neutralizing antibody vaccine for pandemic and pre-emergent coronaviruses

Kevin O. Saunders, Esther Lee, Robert Parks et al. · Nature · 2021 · 276 citations · Full text

, , +14

1–5 of 54